The Pharmaceutical Commons: Sharing and Exclusion in Global Health Drug Development
This article explores the paradoxical role of private property in the new configuration of global health research and development.
In the last decade, the organization of pharmaceutical research on neglected tropical diseases has undergone transformative change. In a context of perceived “market failure,” the development of new medicines is increasingly handled by public-private partnerships. This shift toward hybrid organizational models depends on a particular form of exchange: the sharing of proprietary assets in general and of intellectual property rights in particular.
Javier Lezaun, Catherine M. Montgomery
Science, Technology & Human Values
0162243914542349, July 11, 2014